An approach to the quantitation of immunogenic antigen.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2138493)

Published in J Exp Med on May 01, 1968

Authors

P J McConahey, J C Cerottini, F J Dixon

Articles by these authors

A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20

Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol (1974) 11.12

Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79

Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91

The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06

The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81

Tumor antigens recognized by T lymphocytes. Annu Rev Immunol (1994) 6.16

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03

Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med (1974) 5.37

Localization of mouse isoantigens on the cell surface as revealed by immunofluorescence. Immunology (1967) 5.10

Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol (1987) 5.07

Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens. Nature (1970) 4.84

Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79

Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med (1983) 4.47

Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01

Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96

Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83

Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol (1978) 3.78

Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74

The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61

Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58

Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51

Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol (1985) 3.47

Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40

The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31

Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27

H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature (1987) 3.10

Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int (1973) 3.09

The biology and detection of immune complexes. Adv Immunol (1979) 3.05

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med (1998) 3.04

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med (1999) 2.98

IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol (1979) 2.86

Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med (1979) 2.86

A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med (1982) 2.76

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol (1998) 2.68

Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J Immunol (1978) 2.65

The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64

Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63

Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55

The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54

Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotoxic activity of long-term mixed leukocyte cultures. J Exp Med (1974) 2.52

Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51

Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med (1966) 2.42

Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1. J Immunol (1987) 2.39

Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med (1973) 2.39

Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38

The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37

Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells. J Exp Med (1972) 2.35

Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33

Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev (1980) 2.32

Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25

Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22

The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16

Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J Exp Med (1983) 2.16

Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15

Cellular and humoral response to transplantation antigens. I. Development of alloantibody-forming cells and cytotoxic lymphocytes in the graft-versus-host reaction. J Exp Med (1971) 2.13

Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12

Immunohistochemical study of allergic encephalomyelitis. Am J Pathol (1968) 2.10

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity (2000) 2.10

The immunogenicity of antigen bound to the plasma membrane of macrophages. J Exp Med (1970) 2.08

Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08

Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07

Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07

Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med (1980) 2.07

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease. J Exp Med (1970) 2.06

Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med (1983) 2.06

Circulating immune complexes in infective endocarditis. N Engl J Med (1976) 2.02

Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol (1980) 2.01

Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. Virology (1970) 2.00

In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (1974) 1.96

Persistence of antigen on the surface of macrophages. Nature (1969) 1.95

Immune response to a hapten coupled to a nonimmunogenic carrier. Influence of lipopolysaccharide. J Exp Med (1972) 1.95

Antigen quantitation in experimental immune complex glomerulonephritis. I. Acute serum sickness. J Immunol (1970) 1.93

Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance. J Exp Med (1974) 1.91

Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens. J Exp Med (1967) 1.90

The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88

Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med (1969) 1.87

Surface markers of cloned human T cells with various cytolytic activities. J Exp Med (1981) 1.87

Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol (1983) 1.81

B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med (1983) 1.79

Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol (2001) 1.77

Experimental allergic glomerulonephritis induced in the rabbit with homologous renal antigens. J Exp Med (1967) 1.76

The antibody responses of rabbits and rats to hemocyanin. J Immunol (1966) 1.75

Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med (1971) 1.74

Separation of stages in the development of the "T" cells involved in cell-mediated immunity. J Exp Med (1972) 1.73

The function of macrophages in the immune response. Semin Hematol (1970) 1.71